Optivise Advisory Services’s Inspire Corporate Bond ETF IBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.23M Sell
51,632
-1,330
-3% -$31.7K 0.62% 43
2026
Q1
$1.26M Sell
52,962
-2,346
-4% -$56.5K 0.77% 32
2025
Q4
$1.34M Buy
55,308
+26,592
+93% +$643K 0.77% 37
2025
Q3
$693K Sell
28,716
-1,150
-4% -$27.7K 0.41% 63
2025
Q2
$717K Sell
29,866
-1,105
-4% -$26.2K 0.37% 69
2025
Q1
$736K Buy
30,971
+2,589
+9% +$61.2K 0.41% 63
2024
Q4
$665K Buy
28,382
+1,798
+7% +$42.7K 0.36% 73
2024
Q3
$640K Buy
26,584
+1,119
+4% +$26.7K 0.34% 66
2024
Q2
$594K Buy
+25,465
New +$593K 0.32% 72

Other funds holding IBD

Optivise Advisory Services's IBD Position: Q2 2026 in Review

Optivise Advisory Services reduced its Inspire Corporate Bond ETF (IBD) stake by 2.5% in Q2 2026, selling an estimated $31.7K and leaving 51,632 shares worth $1.23M. The position accounts for 0.62% of the portfolio, ranked #43.

Optivise Advisory Services first reported a position in IBD in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.34M in Q4 2025. 38 funds tracked by Wall St. Rank hold IBD as of Q2 2026.

  • Optivise Advisory Services held 51,632 shares of Inspire Corporate Bond ETF worth $1.23M as of Q2 2026.
  • Optivise Advisory Services sold 1,330 Inspire Corporate Bond ETF shares in Q2 2026, an estimated $31.7K.
  • Inspire Corporate Bond ETF made up 0.62% of Optivise Advisory Services's portfolio in Q2 2026, its #43 holding.
  • Optivise Advisory Services first reported a position in Inspire Corporate Bond ETF in Q2 2024 and has held it in 9 quarters since.
  • Optivise Advisory Services's Inspire Corporate Bond ETF position peaked at $1.34M in Q4 2025.
  • 38 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q2 2026.

Based on Optivise Advisory Services's 13F filing for Q2 2026, filed 13 Jul 2026.